Empowering physicians,
Enriching care in pediatric rheumatology

The JIR Academy is an online platform for pediatric rheumatologists, providing updates on the latest trends and offering opportunities to engage with a worldwide community. We help you tackle your Monday morning clinical questions.

Access Members (Until end of January 2025)

Important changes

As we celebrate six months of JIR Academy, we’re evolving to serve you better:

🚫 Subscriptions End: All monthly subscriptions stop on December 1st. Annual subscribers will receive pro-rata reimbursements - Content remains accessible until January 31st, 2025.
🌐 New Page Coming: We’re building a free-access public page, Stay tuned!
🎙️ Monthly Podcasts: Starting in December, we will be releasing one free podcast per month on Spotify and YouTube.
💡 Clinical Case Discussions: These continue monthly and remain free for all (dates announced in newsletters, on our website, and social media).

Thank you for being part of JIR Academy’s journey. Stay tuned for exciting updates as we step into this new phase!

Pediatric Rheumatology in Bytes and Bits

Engage in monthly case discussions

Share your challenging cases, your thoughts, your questions. It is a small world after all. Our invited faculty may contribute to collective learning.

Tune in to our weekly practice podcasts

Aimed at changing your Monday morning approach featuring discussions on recent publications, guidelines, and insights in pediatric rheumatology.

Independent teaching

An independent educational initiative led by Prof. Michaël Hofer from Switzerland and Dr Raju Khubchandani from India.

Our forum operates without industry funding with no conflicts to declare.

Free Podcasts

09:18

Episode 17 - IgA Vasculitis Nephritis Tips on Diagnosis and Management for the Practitioner

IgA Vasculitis remains the commonest form of vasculitis in childhood and Nephritis is the most important long term prognostic indicator. Michael and Raju review a paper and share some of their experiences.

11:34

Episode 14 - When the first dose of IVIG fails in Kawasaki disease

IVIG resistance is a major challenge in about 15% of children with Kawasaki disease. The cost and availability of IVIG are challenges which have led to examining alternatives to the second dose of IVIG. This episode is Free. If you are interested to watch more, go to jircohorte.org/academyforum

10:41

Episode 03 - The many "faces" of JIA - TMJ involvement.

Michael and Raju discuss learnings from some Danish papers on consequences of involvement of the TM joint and describe the 2 minute internationally derived multidisciplinary protocol to evaluate this joint at every visit. This episode is Free. If you are interested to watch more, go to https://www.jircohorte.org/jiracademyforum

10:02

Episode 08 - Fetal bradycardia and the pediatric rheumatologist

Obstetricians may reach out directly or via neonatologists for persistent fetal bradycardia.Congenital complete heart block due to neonatal lupus is discussed. This episode is Free. If you are interested to watch more, go to https://www.jircohorte.org/jiracademyforum

Or Listen on Spotify

Our Experts

Meet the minds behind our initiative. With an unwavering commitment to impartial education and advancement, our faculty ensure the authenticity and quality of pediatric rheumatology education.

Pr. Michael Hofer

Senior consultant in pediatric rheumatologist and immunology, Lausanne (Switzerland)

Dr. Raju Khubchandani

Senior consultant pediatric rheumatologist in Mumbai (India).

Empowering physicians, Enriching care in pediatric rheumatology